|
1
|
Stromberg U, Peterson S, Holmén A,
Holmberg E, Hultcrantz R, Martling A and Nilbert M: Rational
targeting of population groups and residential areas for colorectal
cancer screening. Cancer Epidemiol. 60:23–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jung C, Kim RS, Zhang H, Lee SJ, Sheng H,
Loehrer PJ, Gardner TA, Jeng MH and Kao C: HOXB13 is downregulated
in colorectal cancer to confer TCF4-mediated transactivation. Br J
Cancer. 92:2233–2239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hosokawa A, Yamada Y, Shimada Y, Muro K,
Hamaguchi T, Morita H, Araake M, Orita H and Shirao K: Prognostic
significance of thymidylate synthase in patients with metastatic
colorectal cancer who receive protracted venous infusions of
5-fluorouracil. Int J ClinOncol. 9:388–392. 2004.
|
|
4
|
Tian Y, Xu B, Yu G, Li Y and Liu H:
Comorbidity and the risk of anastomotic leak in Chinese patients
with colorectal cancer undergoing colorectal surgery. Int J
Colorectal Dis. 32:947–953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo X, Zhang C, Ma W, Tian F, Xu G, Han X,
Sun P, Baklaushev VP, Bryukhovetskiy AS, Wang G, et al: Patterns of
bone metastases in newly diagnosed colorectal cancer: A real-world
analysis in the SEER database. Int J Colorectal Dis. 34:533–543.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahmed S, Johnson K, Ahmed O and Iqbal N:
Advances in the management of colorectal cancer: From biology to
treatment. Int J Colorectal Dis. 29:1031–1042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mele V, Sokol L, Kolzer VH, Pfaff D,
Muraro MG, Keller I, Stefan Z, Centeno I, Terracciano LM, Dawson H,
et al: The hyaluronan-mediated motility receptor RHAMM promotes
growth, invasiveness and dissemination of colorectal cancer.
Oncotarget. 8:70617–70629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang KM, Park IJ, Lee JL, Kim CW, Yoon YS,
Lim SB, Yu CS and Kim JC: Benefits of repeated resections for liver
and lung metastases from colorectal cancer. Asian J Surg.
43:102–109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Price TJ, Tang M, Gibbs P, Haller DG,
Peeters M, Arnold D, Segelov E, Roy A, Tebbutt N, Pavlakis N, et
al: Targeted therapy for metastatic colorectal cancer. Expert Rev
Anticancer Ther. 18:991–1006. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamamoto H and Mori M: MicroRNAs as
therapeutic targets and colorectal cancer therapeutics. Adv Exp Med
Biol. 937:239–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun L, Zhang Y, Zhang Y, Gu Y, Xuan L, Liu
S, Zhao X, Wang N, Huang L, Huang Y, et al: Expression profile of
long non-coding RNAs in a mouse model of cardiac hypertrophy. Int J
Cardiol. 177:73–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanly DJ, Esteller M and Berdasco M:
Interplay between long non-coding RNAs and epigenetic machinery:
Emerging targets in cancer? Philos Trans R Soc Lond B Biol Sci.
373:201700742018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai L, Li J, Dong Z, Liu Y, Chen Y, Chen
N, Cheng L, Fang C, Wang H, Ji Y, et al: Temporal expression and
functional analysis of long non-coding RNAs in colorectal cancer
initiation. J Cell Mol Med. 23:4127–4138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao X, Yin H, Li N, Zhu Y, Shen W, Qian
S, He G, Li J and Wang X: An integrated regulatory network based on
comprehensive analysis of mRNA expression, gene methylation and
expression of long non-coding RNAs (lncRNAs) in myelodysplastic
syndromes. Front Oncol. 9:2002019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Z: Long non-coding RNAs in
Alzheimer's disease. Curr Top Med Chem. 16:511–519. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanson A, Wilhelmsen D and DiStefano JK:
The role of long non-coding RNAs (lncRNAs) in the development and
progression of fibrosis associated with nonalcoholic fatty liver
disease (NAFLD). Noncoding RNA. 4:E182018.PubMed/NCBI
|
|
17
|
Zhang P, Cao L, Zhou R, Yang X and Wu M:
The lncRNA Neat1 promotes activation of inflammasomes in
macrophages. Nat Commun. 10:14952019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie X, Tang B, Xiao YF, Xie R, Li BS, Dong
H, Zhou JY and Yang SM: Long non-coding RNAs in colorectal cancer.
Oncotarget. 7:5226–5239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Gong B, Jiang ZL, Zhong S, Liu XC,
Dong K, Wu HS, Yang HJ and Zhu SK: Microarray expression profile
analysis of long non-coding RNAs in pancreatic ductal
adenocarcinoma. Int J Oncol. 48:670–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen J, Wang H, Dong T, Gan P, Fang H, Wu
S, Li J, Zhang Y, Du R and Zhu Q: STAT3-induced upregulation of
lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid
carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT
signalling pathway. Cell Prolif. 52:e125692019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang P, Dong Q, Zhu H, Li S, Shi L and
Chen X: Long non-coding antisense RNA GAS6-AS1 supports gastric
cancer progression via increasing GAS6 expression. Gene. 696:1–9.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Yang X, Chen Z, Tian L, Jiang G,
Chen F, Li J, An P, Lu L, Luo N, et al: m6A-induced
lncRNA RP11 triggers the dissemination of colorectal cancer cells
via upregulation of Zeb1. Mol Cancer. 18:872019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barresi V, Trovato-Salinaro A, Spampinato
G, Musso N, Castorina S, Rizzarelli E and Condorelli DF:
Transcriptome analysis of copper homeostasis genes reveals
coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal
cancer. FEBS Open Bio. 6:794–806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barresi V, Cinnirella G, Valenti G,
Spampinato G, Musso N, Castorina S and Condorelli DF: Gene
expression profiles in genome instability-based classes of
colorectal cancer. BMC Cancer. 18:12652018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Condorelli DF, Spampinato G, Valenti G,
Musso N, Castorina S and Barresi V: Positive caricature
transcriptomic effects associated with broad genomic aberrations in
colorectal cancer. Sci Rep. 8:148262018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Zhao Z, Xie CW and Zhao Y:
Dual-targeting liposome modified by glutamic hexapeptide and folic
acid for bone metastatic breast cancer. Chem Phys Lipids.
228:1048822020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loennstedt I and Speed P: Replicated
microarray data. Statistica Sinica. 12:31–46. 2001.
|
|
29
|
Bauer S, Gagneur J and Robinson PN: GOing
Bayesian: Model-based gene set analysis of genome-scale data.
Nucleic Acids Res. 38:3523–3532. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Benjamini Y and Yekutieli D: The control
of the false discovery rate in multiple testing under dependency.
Annals of Statistics. 29:1165–1188. 2001.
|
|
31
|
Best D and Roberts E: Algorithm AS 89: The
upper tail probabilities of Spearman's rho. Applied Statistics.
24:377–379. 1975. View Article : Google Scholar
|
|
32
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mateo-Lozano S, Bazzocco S, Rodrigues P,
Mazzolini R, Andretta E, Dopeso H, Fernández Y, Del Llano E, Bilic
J, Suárez-López L, et al: Loss of the EPH receptor B6 contributes
to colorectal cancer metastasis. Sci Rep. 7:437022017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cerdán-Santacruz C, Cano-Valderrama O,
Cárdenas-Crespo S, Torres-García AJ and Cerdán-Miguel J: Colorectal
cancer and its delayed diagnosis: Have we improved in the past 25
years? Rev Esp Enferm Dig. 103:458–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bai J, Yao B, Wang L, Sun L, Chen T, Liu
R, Yin G, Xu Q and Yang W: lncRNA A1BG-AS1 suppresses proliferation
and invasion of hepatocellular carcinoma cells by targeting
miR-216a-5p. J Cell Biochem. 120:10310–10322. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rossi MN and Antonangeli F: LncRNAs: New
players in apoptosis control. Int J Cell Biol. 2014:4738572014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gioia R, Drouin S, Ouimet M, Caron M,
St-Onge P, Richer C and Sinnett D: Lncrnasdownregulated in
childhood acute lymphoblastic leukemia modulate apoptosis, cell
migration, and DNA damage response. Oncotarget. 8:80645–80650.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin Q, Dai Y, Wang Y, Zhang S and Liu G:
High kinesin family member 11 expression predicts poor prognosis in
patients with clear cell renal cell carcinoma. J ClinPathol.
72:354–362. 2019.
|
|
40
|
Xie JJ, Li WH, Li X, Ye W and Shao CF:
LncRNA MALAT1 promotes colorectal cancer development by sponging
miR-363-3p to regulate EZH2 expression. J Biol Regul Homeost
Agents. 33:331–343. 2019.PubMed/NCBI
|
